Metformin protects the heart against chronic intermittent hypoxia through AMPK ‐dependent phosphorylation of HIF ‐1α
The FEBS Journal · 2025-08 · 292 (15) · 3942-3959
DOI: 10.1111/febs.70110 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, online erschienen am 13.05.2025. Verfasst von Sophie Moulin und 10 weiteren Autor:innen. Beteiligte Einrichtung: HP2, Université Grenoble Alpes, INSERM, Laboratory HP2, France. Hauptthemen laut MEDLINE: Metformin, Hypoxia-Inducible Factor 1, alpha Subunit, AMP-Activated Protein Kinases, Hypoxia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Agir Pour les Maladies Chroniques, Fédération Française de Cardiologie.
Abstract (Originalsprache)
Chronic intermittent hypoxia (IH), a major feature of obstructive sleep apnea syndrome (OSA), is associated with greater severity of myocardial infarction. In this study, we performed RNA sequencing of cardiac samples from mice exposed to IH, which reveals a specific transcriptomic signature of the disease, relative to mitochondrial remodeling and cell death. Corresponding to its activation under chronic IH, we stabilized the Hypoxia Inducible Factor‐1α (HIF‐1α) in cardiac cells in vitro and observed its association with an increased autophagic flux. In accordance, IH induced autophagy and mitophagy, which are decreased in HIF‐1α +/− mice compared to wild‐type animals, suggesting that HIF‐1 plays a significant role in IH‐induced mitochondrial remodeling. Next, we showed that the AMPK metabolic sensor, typically activated by mitochondrial stress, is inhibited after 3 weeks of IH in hearts. Therefore, we assessed the effect of metformin, an anti‐diabetic drug and potent activator of AMPK, on myocardial response to ischemia–reperfusion (I/R) injury. Daily administration of metformin significantly decreases infarct size without any systemic beneficial effect on insulin resistance under IH conditions. The cardioprotective effect of metformin was lost in AMPKα2 knock‐out mice, demonstrating that AMPKα2 isoform promotes metformin‐induced cardioprotection in mice exposed to IH. Mechanistically, we found that metformin inhibits IH‐induced mitophagy in myocardium and decreases HIF‐1α nuclear expression in mice subjected to IH. In vitro experiments demonstrated that metformin induced HIF‐1α phosphorylation, decreased its nuclear localization, and HIF‐1 transcriptional activity. Collectively, these results identify the AMPKα2 metabolic sensor as a novel modulator of HIF‐1 activity. Our data suggest that metformin could be considered as a cardioprotective drug in OSA patients independently of their metabolic status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HP2, Université Grenoble Alpes, INSERM, Laboratory HP2, France.
- Institut NeuroMyoGène, CNRS UMR 5261, INSERM U1315, Université Lyon 1, France.
- Team Atherosclerosis, Thrombosis and Physical Activity, LIBM UR7424, Université Lyon 1, France.
- Pole of Cardiovascular Research, UCLouvain, Institute of Experimental and Clinical Research (IREC), Brussels, Belgium.
- Cardiovascular and Respiratory Function Laboratory, Grenoble Alpes University Hospital, France.
- WELBIO Department, WEL Research Institute, Wavre, Belgium.
ORCID-Profile: Elise Belaidi
Förderung
- Agir Pour les Maladies Chroniques
- Fédération Française de Cardiologie
Zitieren
APA
Moulin, S., Blachot-Minassian, B., Kneppers, A., Thomas, A., Paradis, S., Bultot, L., Arnaud, C., Pépin, J. L., Bertrand, L., Mounier, R., & Belaidi, E. (2025). Metformin protects the heart against chronic intermittent hypoxia through AMPK ‐dependent phosphorylation of HIF ‐1α. The FEBS Journal, 292(15), 3942-3959. https://doi.org/10.1111/febs.70110
Vancouver
Moulin S, Blachot-Minassian B, Kneppers A, Thomas A, Paradis S, Bultot L, et al. Metformin protects the heart against chronic intermittent hypoxia through AMPK ‐dependent phosphorylation of HIF ‐1α. The FEBS Journal. 2025;292(15):3942-3959. doi:10.1111/febs.70110
BibTeX
@article{Moulin2025,
author = {Moulin, Sophie and Blachot-Minassian, Britanny and Kneppers, Anita and Thomas, Amandine and Paradis, Stéphanie and Bultot, Laurent and Arnaud, Claire and Pépin, Jean-Louis and Bertrand, Luc and Mounier, Rémi and Belaidi, Elise},
title = {Metformin protects the heart against chronic intermittent hypoxia through AMPK ‐dependent phosphorylation of HIF ‐1α},
journal = {The FEBS Journal},
year = {2025},
volume = {292},
number = {15},
pages = {3942--3959},
doi = {10.1111/febs.70110}
}
EUVIMED